Your session is about to expire
← Back to Search
Dietary Supplement
Synaquell for Healthy Subjects
N/A
Waitlist Available
Led By Michael J Stuart, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, postseason (approximately 6 months)
Awards & highlights
Study Summary
This trial is investigating whether the dietary supplement Synaquell can improve brain function.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, postseason (approximately 6 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, postseason (approximately 6 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Body Weight Changes
Change in brain vital signs
Secondary outcome measures
Change in King-Devick Test (KDT) scores
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Synaquell GroupExperimental Treatment1 Intervention
Subjects will receive the dietary supplement, Synaquell, twice-daily during the hockey season.
Group II: Placebo GroupPlacebo Group1 Intervention
Subjects will receive the placebo twice-daily, during the hockey season.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Synaquell
2021
N/A
~140
Find a Location
Who is running the clinical trial?
Thorne Research Inc.Industry Sponsor
10 Previous Clinical Trials
626 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,730 Total Patients Enrolled
HealthTech Connex Inc.Industry Sponsor
4 Previous Clinical Trials
124 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger